Cannabinoid Hyperemesis Syndrome
Tracking # 20-1043492
$99999.00
Course overview
Regular medical and recreational use of cannabis is on the rise among all age groups. In most cases, this is associated with few side effects, but some regular users experience a wildly paradoxical reaction. While cannabis will normally suppress nausea and pain and stimulate appetite, weekly cannabis use can sometimes produce severe cramping, abdominal pain, vomiting, and nausea known as cannabinoid hyperemesis syndrome (CHS). In this course, we explore the pathophysiology of CHS, discuss presentations that EMS may encounter, and review the current diagnostic and treatment criteria. Current estimates are that cannabinoid hyperemesis syndrome affects potentially 2.7 million people in the United States annually, with significant increases in states with legalization. With complications of CHS including kidney failure, electrolyte imbalance, and skin burns on patients seeking self-treatment, can EMS providers afford to be unprepared?
Subject areas
This course counts toward the state boards and subject areas below.
Florida Emergency Medical Services
Emergency Medical Technician
Paramedic
Tennessee Emergency Medical Services Board
Advanced Emergency Medical Technician
Emergency Medical Responder
Emergency Medical Technician
Paramedic
Paramedic Critical Care
Disclosure statements
The user acknowledges and agrees that Clarion Events, Inc., its officers, agents, managers, employees, contractors, subcontractors, content providers, or other related parties will have no liability whatsoever to the user or any other party arising from this course, or any act or omission by the user or any other party pursuant to, or in reliance on, this course. The user specifically waives any such claims against Clarion Events, Inc. and the user shall be solely responsible for any outcome related to or arising from this course.